Reliq Health Technologies Inc. (RQHTF) Announces New Trial in Australia with AnglicareSA

“We are very excited to be working with AnglicareSA to improve access to care for older Australians,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.  “AnglicareSA operates six residential care facilities and provides home care to more than 1,500 Australians.  The iUGO Care platform will enable AnglicareSA to trial remote patient monitoring services for clients in their own homes, improving access to care for patients with chronic diseases.  Reliq is starting to gain significant traction in Australia, where the government has made home care a priority with the Increasing Choice in Home Care measure, implemented in 2017.  With over 3.5 million Australians aged 65 and over and a progressive single payer system that has committed significant funding to home care, the Australian market is a perfect fit for Reliq’s iUGO Care platform.”

“AnglicareSA respects and cares for older people in their own homes, in residential aged care facilities and in the community,” said Daniel Aitchison, of AnglicareSA.  “We are committed to supporting older people to live full and rewarding lives and to respecting their choices.  We look forward to trialing Reliq Health remote monitoring services as we continue to deliver high quality care and support to our clients and their families.”

ON BEHALF OF THE BOARD

“Dr. Lisa Crossley”

CEO and Director

ABOUT RELIQ HEALTH

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators.  iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery.  iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.

For further information contact:

Investor Relations at Reliq Health at IR@reliqhealth.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.